We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
-4.41%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$6.21B
AUM Growth
-$804M
Cap. Flow
-$184M
Cap. Flow %
-2.96%
Top 10 Hldgs %
40.63%
Holding
166
New
10
Increased
38
Reduced
80
Closed
12

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$32.4M
2
UNH icon
UnitedHealth
UNH
+$23.7M
3
CI icon
Cigna
CI
+$21.4M
4
HUM icon
Humana
HUM
+$20.1M
5
APLS
Apellis Pharmaceuticals
APLS
+$12.1M

Top Sells

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$72.3M
2
MDT icon
Medtronic
MDT
+$64.4M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$33M
4
CRL icon
Charles River Laboratories
CRL
+$17.5M
5
TMO icon
Thermo Fisher Scientific
TMO
+$15.8M

Sector Composition

Rank Sector Weight
1 Healthcare 99.13%
2 Industrials 0.77%
3 Energy 0.04%
4 Communication Services 0.01%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHR icon
51
Danaher
DHR
$143B
$33.9M 0.55%
154,009
-53,215
-26% -$11.9M
TMO icon
52
Thermo Fisher Scientific
TMO
$196B
$33.6M 0.54%
66,468
-29,633
-31% -$15.8M
ATRC icon
53
AtriCure
ATRC
$1.75B
$32.7M 0.53%
747,560
-1,053
-0.1% -$51.4K
ZBH icon
54
Zimmer Biomet
ZBH
$17.6B
$32M 0.52%
284,888
+53
+0% +$6.73K
BMRN icon
55
BioMarin Pharmaceuticals
BMRN
$11.6B
$31M 0.5%
349,888
-10,716
-3% -$953K
CNC icon
56
Centene
CNC
$32.9B
$30.6M 0.49%
444,043
+151,516
+52% +$10.1M
HCM icon
57
HUTCHMED
HCM
$1.93B
$30.6M 0.49%
1,802,963
-2,620
-0.1% -$37.5K
IQV icon
58
IQVIA
IQV
$34B
$30.5M 0.49%
155,220
-6,900
-4% -$1.5M
GMED icon
59
Globus Medical
GMED
$10.4B
$30.3M 0.49%
609,615
-38,030
-6% -$2.13M
APLS
60
DELISTED
Apellis Pharmaceuticals
APLS
$30.2M 0.49%
793,841
+275,346
+53% +$12.1M
MRK icon
61
Merck
MRK
$315B
$30.1M 0.48%
291,896
-14,798
-5% -$1.59M
TMDX icon
62
Transmedics
TMDX
$2.5B
$29.4M 0.47%
536,737
-75,876
-12% -$5.46M
SRPT icon
63
Sarepta Therapeutics
SRPT
$1.85B
$29.3M 0.47%
241,752
+41,532
+21% +$4.69M
PRCT icon
64
Procept Biorobotics
PRCT
$1.08B
$29.1M 0.47%
888,296
+146,779
+20% +$5M
CDNA icon
65
CareDx
CDNA
$2.01B
$27.6M 0.44%
3,940,798
+224,321
+6% +$2.07M
COO icon
66
Cooper Companies
COO
$13.9B
$27.5M 0.44%
346,268
– –
OM icon
67
Outset Medical
OM
$78.4M
$26.2M 0.42%
160,562
-47,830
-23% -$11.3M
WVE icon
68
Wave Life Sciences
WVE
$1.14B
$25.8M 0.42%
4,494,458
– –
EPIX
69
DELISTED
ESSA Pharma
EPIX
$24.4M 0.39%
7,898,583
– –
PRVA icon
70
Privia Health
PRVA
$3.34B
$24.3M 0.39%
1,055,178
-67,466
-6% -$1.72M
BDTX icon
71
Black Diamond Therapeutics
BDTX
$105M
$23.3M 0.38%
8,135,839
– –
SILK
72
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$21.4M 0.35%
1,430,562
+73,799
+5% +$1.54M
CSTL icon
73
Castle Biosciences
CSTL
$722M
$20.7M 0.33%
1,228,031
+103,988
+9% +$1.82M
HOLX
74
DELISTED
Hologic
HOLX
$20.1M 0.32%
290,136
– –
LEGN icon
75
Legend Biotech
LEGN
$4.34B
$18.7M 0.3%
278,154
+2,400
+0.9% +$167K
1 2
3
4 5

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Bellevue Group's Q3 2023 Portfolio in Review

As of Q3 2023, Bellevue Group held 166 positions worth $6.21B, down 11% from $7.01B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Bellevue Group's Q3 2023 filing shows 10 new, 38 increased, 80 reduced and 12 closed positions. Its largest new stake was Viatris: 176,848 shares worth $1.74M. The largest sale was Inspire Medical Systems, an estimated $72.3M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier, followed by Industrials and Energy.

  • Bellevue Group's largest Q3 2023 buy was Viatris: 176,848 shares worth $1.74M.
  • Bellevue Group added most to Elevance Health in Q3 2023, an estimated $32.4M increase.
  • Bellevue Group's biggest Q3 2023 reduction was Inspire Medical Systems, cutting an estimated $72.3M.
  • Bellevue Group fully exited Baxter International in Q3 2023, selling an estimated $9.72M.
  • Bellevue Group's ten largest holdings make up 41% of its $6.21B portfolio in Q3 2023.
  • Bellevue Group opened 10 new positions and closed 12 in Q3 2023.
  • Bellevue Group's portfolio value fell 11% quarter-over-quarter to $6.21B.

Based on Bellevue Group's 13F filing for Q3 2023, filed 14 Nov 2023.